IP Verse

Wuesthoff & Wuesthoff patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Wuesthoff & Wuesthoff

Explore patent oppositions filed by Wuesthoff & Wuesthoff against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
EP3638243
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 5, 2025
EP3490582
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025
EP4089071
Xylylene Diisocyanate Composition, Modified Xylylene Diisocyanate Composition, Polymerizable Composition, Resin, Molded Body, Optical Element, And LensMITSUI CHEMICALSFeb 12, 2025
EP3227447
Guide Rna With Chemical ModificationsAGILENTJan 14, 2025
EP3226887
Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024
EP3460063
Methods And Compositions For The Targeted Modification Of A GenomeREGENERON PHARMACEUTICALSDec 12, 2024
EP3380121
Methods For Treating Eye DisordersACCELERON PHARMASep 18, 2024
EP3626270
New UseNOVARTISJul 10, 2024
EP3384049
Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALSApr 24, 2024

Top competitors of Wuesthoff & Wuesthoff

List of top competitors of Wuesthoff & Wuesthoff based on patent oppositions.